References

  1. Debbagh A , Bennani S , Jouhadi H , Joual A, Mrini M EL, Kahlain A, Benjelloun S. Tumeur de sac vitellin : à propos d'un cas. Ann Urol. 2001; 35(6):356-358. PubMed | Google Scholar

  2. Flamant F, Nihoul-Fekete C, Lemerle J. Optimal treatment of clinical stage I Yolk Sac Tumour of the testis. J Paediatric Surgery. 1986; 21(2): 108-111. PubMed | Google Scholar

  3. Hotte SJ, Jewett M, Chin J. Management of stage I Non seminomatous testicular cancer. Clin Oncol. 2010 Feb; 22(1): 17-26. PubMed | Google Scholar

  4. Foster RS, Hermans B, Bihrle R, Donohue JP. Clinical stage I pure Yolk sac tumour of the testis in adult has different clinical behaviour than juvenile Yolk sac tumour. J Urol . 2000 Dec ; 164 (6) : 1943-194. PubMed | Google Scholar

  5. Jonathan HR. Pre pubertal testicular tumours. Urology. 2009 Jul; 74 (1): 94-99. PubMed | Google Scholar

  6. Culine S. Prise en charge des tumeurs germinales non séminomateuses de stade I après orchidectomie, comité de cancérologie de l'AFU. Progrès Urol. 2007; 17 : 1035-1045. PubMed | Google Scholar

  7. Schmoll HJ, Souchon R, Krege S et al. European consensus on diagnostic and treatment of germ cell cancer. Ann Oncol. 2004(Sep); 15 (9): 1377-1399. PubMed | Google Scholar

  8. Culine S, Kerbrat P, Kramar A. Refining the optimal the optimal chemotherapy regimen for good risk metastatic non seminomatous germ cell tumours. Ann Oncol. 2007 May; 18(5): 917-924. PubMed | Google Scholar